Smarter. Stronger. Together: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer

Gain perspectives on strategies for optimizing use of CDK4/6 and PI3K inhibitors for HR+/HER2- breast cancer including discussion on effective patient education about these targeted oral therapies! Learn from the experts with downloadable slides commentaries podcast on-demand Webcast and an Interactive Decision Support Tool providing personalized management recommendations for adverse events associated with CDK4/6 and PI3K inhibitors.

Resources for your patients: https://www.smartpatients.com/resources/cco-breast-cancer

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Supporters

Supported by an educational grant from

Lilly

Partners

Smart Patients

ProCE Banner